North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period. The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs market […]
